Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-22-043770

Chief Legal Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derovan Netanel Chief Legal Officer 2022-07-28 Grant or award +30,000 48,000 D
Loading xslF345X03/doc4.xml…